High frequencies of polyfunctional CD8+ NK cells in chronic HIV-1 infection are associated with slower disease progression

Journal of Virology

Volumn 88, Issue 21, 2014, Pages 12397-12408

  Ahmad, Fareed ^a   Hong, Henoch S ^b   Jäckel, Marc ^a   Jablonka, Alexandra ^a   Lu, I Na ^a   Bhatnagar, Nupur ^a   Eberhard, Johanna M ^a   Bollmann, Benjamin A ^a   Ballmaier, Matthias ^a   Zielinska Skowronek, Margot ^a   Schmidt, Reinhold E ^a   Meyer Olson, Dirk ^a,c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

^c M and i Fachklinik Bad Pyrmont   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD57 ANTIGEN; T LYMPHOCYTE RECEPTOR; CD3 ANTIGEN; CD8 ANTIGEN;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ CD3- T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CD8- T LYMPHOCYTE; CELL LOSS; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INNATE IMMUNITY; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; RETROSPECTIVE STUDY; VIRUS LOAD; CHEMISTRY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; LYMPHOCYTE SUBPOPULATION; VIROLOGY;

ANTIGENS, CD3; ANTIGENS, CD8; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; HIV INFECTIONS; HIV-1; HUMANS; KILLER CELLS, NATURAL; LONGITUDINAL STUDIES; LYMPHOCYTE SUBSETS; RETROSPECTIVE STUDIES;

EID: 84907967254     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01420-14     Document Type: Article

References (59)

1. Caligiuri MA. 2008. Human natural killer cells. Blood 112:461-469. http: //dx.doi.org/10.1182/blood-2007-09-077438.
2. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S. 2011. Innate or adaptive immunity? The example of natural killer cells. Science 331:44-49. http://dx.doi.org/10.1126/science.1198687.
3. Cooper MA, Fehniger TA, Caligiuri MA. 2001. The biology of human natural killer-cell subsets. Trends Immunol. 22:633-640. http://dx.doi.org/10.1016/S1471-4906(01)02060-9.
4. Lanier LL. 2005. NK cell recognition. Annu. Rev. Immunol. 23:225-274. http://dx.doi.org/10.1146/annurev.immunol.23.021704.115526.
5. Berahovich RD, Lai NL, Wei Z, Lanier LL, Schall TJ. 2006. Evidence for NK cell subsets based on chemokine receptor expression. J. Immunol. 177:7833-7840. http://dx.doi.org/10.4049/jimmunol.177.11.7833.
6. Moller MJ, Kammerer R, von Kleist S. 1998. A distinct distribution of natural killer cell subgroups in human tissues and blood. Int. J. Cancer 78:533-538. http://dx.doi.org/10.1002/(SICI)1097-0215(19981123)78:5<533::AID-IJC1>3.0.CO;2-2.
7. Carrega P, Ferlazzo G. 2012. Natural killer cell distribution and trafficking in human tissues. Front. Immunol. 3:347. http://dx.doi.org/10.3389 /fimmu.2012.00347.
8. Jonges LE, Albertsson P, van Vlierberghe RL, Ensink NG, Johansson BR, van de Velde CJ, Fleuren GJ, Nannmark U, Kuppen PJ. 2001. The phenotypic heterogeneity of human natural killer cells: presence of at least 48 different subsets in the peripheral blood. Scand. J. Immunol. 53:103-110 http://dx.doi.org/10.1046/j.1365-3083.2001.00838.x.
9. Addison EG, North J, Bakhsh I, Marden C, Haq S, Al-Sarraj S, Malayeri R, Wickremasinghe RG, Davies JK, Lowdell MW. 2005. Ligation of CD8alpha on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activity. Immunology 116:354-361. http://dx.doi.org/10.1111/j.1365-2567.2005.02235.x.
10. Martin MP, Qi Y, Gao X, Yamada E, Martin JN, Pereyra F, Colombo S, Brown EE, Shupert WL, Phair J, Goedert JJ, Buchbinder S, Kirk GD, Telenti A, Connors M, O' Brien SJ, Walker BD, Parham P, Deeks SG, McVicar DW, Carrington M. 2007. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39:733-740. http://dx.doi.org/10.1038/ng2035.
11. Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, Trowsdale J, Wilson M, O' Brien SJ, Carrington M. 2002. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31:429-434. http://dx.doi.org /10.1038/ng934.
12. Alter G, Martin MP, Teigen N, Carr WH, Suscovich TJ, Schneidewind A, Streeck H, Waring M, Meier A, Brander C, Lifson JD, Allen TM, Carrington M, Altfeld M. 2007. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J. Exp. Med. 204:3027-3036. http://dx.doi.org/10.1084/jem.20070695.
13. Kamya P, Boulet S, Tsoukas CM, Routy JP, Thomas R, Cote P, Boulassel MR, Baril JG, Kovacs C, Migueles SA, Connors M, Suscovich TJ, Brander C, Tremblay CL, Bernard N, Canadian Cohort of HIV Infected Slow Progressors. 2011. Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57. J. Virol. 85:5949-5960. http: //dx.doi.org/10.1128/JVI.02652-10.
14. Koehler RN, Alter G, Tovanabutra S, Saathoff E, Arroyo MA, Walsh AM, Sanders-Buell EE, Maboko L, Hoelscher M, Robb ML, Michael NL, McCutchan FE, Kim JH, Kijak GH. 2013. Natural killer cell-mediated innate sieve effect on HIV-1: the impact of KIR/HLA polymorphism on HIV-1 subtype-specific acquisition in east Africa. J. Infect. Dis. 208:1250-1254 http://dx.doi.org/10.1093/infdis/jit349.
15. Alter G, Heckerman D, Schneidewind A, Fadda L, Kadie CM, Carlson JM, Oniangue-Ndza C, Martin M, Li B, Khakoo SI, Carrington M, Allen TM, Altfeld M. 2011. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 476:96-100. http://dx.doi.org/10.1038/nature10237.
16. Fauci AS, Mavilio D, Kottilil S. 2005. NK cells in HIV infection: paradigm for protection or targets for ambush. Nat. Rev. Immunol. 5:835-843 http://dx.doi.org/10.1038/nri1711.
17. Bjorkstrom NK, Ljunggren HG, Sandberg JK. 2010. CD56 negative NK cells: origin, function, and role in chronic viral disease. Trends Immunol. 31:401-406. http://dx.doi.org/10.1016/j.it.2010.08.003.
18. Hong HS, Ahmad F, Eberhard JM, Bhatnagar N, Bollmann BA, Keudel P, Ballmaier M, Zielinska-Skowronek M, Schmidt RE, Meyer-Olson D. 2012 Loss of CCR7 expression on CD56(bright) NK cells is associated with a CD56(dim)CD16(+) NK cell-like phenotype and correlates with HIV viral load. PLoS One 7:e44820. http://dx.doi.org/10.1371/journal.pone.0044820.
19. Hong HS, Eberhard JM, Keudel P, Bollmann BA, Ahmad F, Ballmaier M, Bhatnagar N, Zielinska-Skowronek M, Schmidt RE, Meyer-Olson D. 2010 Phenotypically and functionally distinct subsets contribute to the expansion of CD56-/CD16+ natural killer cells in HIV infection. AIDS 24:1823-1834. http://dx.doi.org/10.1097/QAD.0b013e32833b556f.
20. Hong HS, Eberhard JM, Keudel P, Bollmann BA, Ballmaier M, Bhatnagar N, Zielinska-Skowronek M, Schmidt RE, Meyer-Olson D. 2010. HIV infection is associated with a preferential decline in less-differentiated CD56dim CD16+ NK cells. J. Virol. 84:1183-1188. http://dx.doi.org/10.1128/JVI.01675-09.
21. Slyker JA, Lohman-Payne B, John-Stewart GC, Dong T, Mbori-Ngacha D, Tapia K, Atzberger A, Taylor S, Rowland-Jones SL, Blish CA. 2012. The impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life. Front. Immunol. 3:399. http://dx.doi.org/10.3389/fimmu.2012.00399.
22. Gregson JN, Kuri-Cervantes L, Mela CM, Gazzard BG, Bower M, Goodier MR. 2013. Short communication: NKG2C(+) NK cells contribute to increases in CD16(+)CD56(-) cells in HIV type 1(+) individuals with high plasma viral load. AIDS Res. Hum. Retroviruses 29:84-88. http: //dx.doi.org/10.1089/aid.2011.0397.
23. Brunetta E, Hudspeth KL, Mavilio D. 2010. Pathologic natural killer cell subset redistribution in HIV-1 infection: new insights in pathophysiology and clinical outcomes. J. Leukoc. Biol. 88:1119-1130. http://dx.doi.org/10.1189/jlb.0410225.
24. Marras F, Nicco E, Bozzano F, Di Biagio A, Dentone C, Pontali E, Boni S, Setti M, Orofino G, Mantia E, Bartolacci V, Bisio F, Riva A, Biassoni R, Moretta L, De Maria A. 2013. Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation. Proc. Natl. Acad. Sci. U. S. A. 110:11970-11975 http://dx.doi.org/10.1073/pnas.1302090110.
25. Meyer-Olson D, Simons BC, Conrad JA, Smith RM, Barnett L, Lorey SL, Duncan CB, Ramalingam R, Kalams SA. 2010. Clonal expansion and TCR-independent differentiation shape the HIV-specific CD8+effectormemory T-cell repertoire in vivo. Blood 116:396-405. http://dx.doi.org /10.1182/blood-2009-11-254136.
26. Alter G, Malenfant JM, Altfeld M. 2004. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294:15-22. http://dx.doi.org/10.1016/j.jim.2004.08.008.
27. Roederer M, Nozzi JL, Nason MX. 2011. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 79:167-174 http://dx.doi.org/10.1002/cyto.a.21015.
28. Hong HS, Rajakumar PA, Billingsley JM, Reeves RK, Johnson RP. 2013. No monkey business: why studying NK cells in non-human primates pays off. Front. Immunol. 4:32. http://dx.doi.org/10.3389/fimmu.2013.00032.
29. Bjorkstrom NK, Riese P, Heuts F, Andersson S, Fauriat C, Ivarsson MA, Bjorklund AT, Flodstrom-Tullberg M, Michaelsson J, Rottenberg ME, Guzman CA, Ljunggren HG, Malmberg KJ. 2010. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 116:3853-3864. http://dx.doi.org/10.1182/blood-2010-04-281675.
30. Lopez-Verges S, Milush JM, Pandey S, York VA, Arakawa-Hoyt J, Pircher H, Norris PJ, Nixon DF, Lanier LL. 2010. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood 116:3865-3874. http://dx.doi.org/10.1182/blood-2010-04-282301.
31. Kottilil S, Chun TW, Moir S, Liu S, McLaughlin M, Hallahan CW, Maldarelli F, Corey L, Fauci AS. 2003. Innate immunity in human immu-nodeficiency virus infection: effect of viremia on natural killer cell function. J. Infect. Dis. 187:1038-1045. http://dx.doi.org/10.1086/368222.
32. Oliva A, Kinter AL, Vaccarezza M, Rubbert A, Catanzaro A, Moir S, Monaco J, Ehler L, Mizell S, Jackson R, Li Y, Romano JW, Fauci AS. 1998 Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J. Clin. Invest. 102:223-231. http://dx.doi.org/10.1172/JCI2323.
33. Fehniger TA, Herbein G, Yu H, Para MI, Bernstein ZP, O' Brien WA, Caligiuri MA. 1998. Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection. J. Immunol. 161:6433-6438.
34. Kottilil S, Jackson JO, Reitano KN, O' Shea MA, Roby G, Lloyd M, Yang J, Hallahan CW, Rehm CA, Arthos J, Lempicki R, Fauci AS. 2007. Innate immunity in HIV infection: enhanced susceptibility to CD95-mediated natural killer cell death and turnover induced by HIV viremia. J. Acquir. Immune Defic. Syndr. 46:151-159. http://dx.doi.org/10.1097 /QAI.0b013e3180dc9909.
35. Jost S, Altfeld M. 2013. Control of human viral infections by natural killer cells. Annu. Rev. Immunol. 31:163-194. http://dx.doi.org/10.1146 /annurev-immunol-032712-100001.
36. Walker BD, Yu XG. 2013. Unravelling the mechanisms of durable control of HIV-1. Nat. Rev. Immunol. 13:487-498. http://dx.doi.org/10.1038 /nri3478.
37. Migueles SA, Laborico AC, Shupert WL, Sabbaghian MS, Rabin R, Hallahan CW, Van Baarle D, Kostense S, Miedema F, McLaughlin M, Ehler L, Metcalf J, Liu S, Connors M. 2002. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3:1061-1068. http://dx.doi.org/10.1038 /ni845.
38. Dahirel V, Shekhar K, Pereyra F, Miura T, Artyomov M, Talsania S, Allen TM, Altfeld M, Carrington M, Irvine DJ, Walker BD, Chakraborty AK. 2011. Coordinate linkage of HIV evolution reveals regions of immunological vulnerability. Proc. Natl. Acad. Sci. U. S. A. 108: 11530-11535. http://dx.doi.org/10.1073/pnas.1105315108.
39. Scheid JF, Mouquet H, Feldhahn N, Seaman MS, Velinzon K, Pietzsch J, Ott RG, Anthony RM, Zebroski H, Hurley A, Phogat A, Chakrabarti B, Li Y, Connors M, Pereyra F, Walker BD, Wardemann H, Ho D, Wyatt RT, Mascola JR, Ravetch JV, Nussenzweig MC. 2009. Broad diversity of neutralizing antibodies isolated from memory B cells in HIVinfected individuals. Nature 458:636-640. http://dx.doi.org/10.1038 /nature07930.
40. West AP, Jr, Scharf L, Scheid JF, Klein F, Bjorkman PJ, Nussenzweig MC. 2014. Structural insights on the role of antibodies in HIV-1 vaccine and therapy. Cell 156:633-648. http://dx.doi.org/10.1016/j.cell.2014.01.052.
41. Vuillier F, Bianco NE, Montagnier L, Dighiero G. 1988. Selective depletion of low-density CD8+, CD16+ lymphocytes during HIV infection. AIDS Res. Hum. Retroviruses 4:121-129. http://dx.doi.org/10.1089/aid.1988.4.121.
42. Lucia B, Jennings C, Cauda R, Ortona L, Landay AL. 1995. Evidence of a selective depletion of a CD16+ CD56+ CD8+ natural killer cell subset during HIV infection. Cytometry 22:10-15. http://dx.doi.org/10.1002 /cyto.990220103.
43. Toth FD, Mosborg-Petersen P, Kiss J, Aboagye-Mathiesen G, Zdravkovic M, Hager H, Ebbesen P. 1993. Differential replication of human immunodeficiency virus type 1 in CD8-and CD8+ subsets of natural killer cells: relationship to cytokine production pattern. J. Virol. 67:5879-5888.
44. Valentin A, Rosati M, Patenaude DJ, Hatzakis A, Kostrikis LG, Lazanas M, Wyvill KM, Yarchoan R, Pavlakis GN. 2002. Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy. Proc. Natl. Acad. Sci. U. S. A. 99:7015-7020. http://dx.doi.org/10.1073/pnas.102672999.
45. Vokurkova D, Sinkora J, Vavrova J, Rezacova M, Knizek J, Ostereicher J. 2006. CD8+natural killer cells have a potential of a sensitive and reliable biodosimetric marker in vitro. Physiol. Res. 55:689-698.
46. Spaggiari GM, Contini P, Carosio R, Arvigo M, Ghio M, Oddone D, Dondero A, Zocchi MR, Puppo F, Indiveri F, Poggi A. 2002. Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily. Blood 99:1706-1714. http: //dx.doi.org/10.1182/blood.V99.5.1706.
47. Torres-Nagel N, Kraus E, Brown MH, Tiefenthaler G, Mitnacht R, Williams AF, Hunig T. 1992. Differential thymus dependence of rat CD8 isoform expression. Eur. J. Immunol. 22:2841-2848. http://dx.doi.org/10.1002/eji.1830221113.
48. Mair KH, Mullebner A, Essler SE, Duvigneau JC, Storset AK, Saalmuller A, Gerner W. 2013. Porcine CD8alphadim/-NKp46high NK cells are in a highly activated state. Vet. Res. 44:13. http://dx.doi.org/10.1186 /1297-9716-44-13.
49. Kieffer LJ, Bennett JA, Cunningham AC, Gladue RP, McNeish J, Kavathas PB, Hanke JH. 1996. Human CD8 alpha expression in NK cells but not cytotoxic T cells of transgenic mice. Int. Immunol. 8:1617-1626. http: //dx.doi.org/10.1093/intimm/8.10.1617.
50. Gibbings D, Befus AD. 2009. CD4 and CD8: an inside-out coreceptor model for innate immune cells. J. Leukoc. Biol. 86:251-259. http://dx.doi.org/10.1189/jlb.0109040.
51. Webster RL, Johnson RP. 2005. Delineation of multiple subpopulations of natural killer cells in rhesus macaques. Immunology 115:206-214. http: //dx.doi.org/10.1111/j.1365-2567.2005.02147.x.
52. Reeves RK, Gillis J, Wong FE, Yu Y, Connole M, Johnson RP. 2010. CD16-natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection. Blood 115:4439-4446. http://dx.doi.org/10.1182/blood-2010-01-265595.
53. Rutjens E, Mazza S, Biassoni R, Koopman G, Ugolotti E, Fogli M, Dubbes R, Costa P, Mingari MC, Greenwood EJ, Moretta L, De Maria A, Heeney JL. 2010. CD8+ NK cells are predominant in chimpanzees, characterized by high NCR expression and cytokine production, and preserved in chronic HIV-1 infection. Eur. J. Immunol. 40:1440-1450. http: //dx.doi.org/10.1002/eji.200940062.
54. Reeves RK, Evans TI, Fultz PN, Johnson RP. 2011. Potential confusion of contaminating CD16+ myeloid DCs with anergic CD16+ NK cells in chimpanzees. Eur. J. Immunol. 41:1070-1074. http://dx.doi.org/10.1002 /eji.201040832.
55. Kestens L, Vingerhoets J, Peeters M, Vanham G, Vereecken C, Penne G, Niphuis H, van Eerd P, van der Groen G, Gigase P, Heeney J. 1995. Phenotypic and functional parameters of cellular immunity in a chimpanzee with a naturally acquired simian immunodeficiency virus infection. J. Infect. Dis. 172:957-963. http://dx.doi.org/10.1093/infdis/172.4.957.
56. Rodriguez AR, Arulanandam BP, Hodara VL, McClure HM, Cobb EK, Salas MT, White R, Murthy KK. 2007. Influence of interleukin-15 on CD8+ natural killer cells in human immunodeficiency virus type 1-infected chimpanzees. J. Gen. Virol. 88:641-651. http://dx.doi.org/10.1099 /vir.0.82154-0.
57. Keele BF, Jones JH, Terio KA, Estes JD, Rudicell RS, Wilson ML, Li Y, Learn GH, Beasley TM, Schumacher-Stankey J, Wroblewski E, Mosser A, Raphael J, Kamenya S, Lonsdorf EV, Travis DA, Mlengeya T, Kinsel MJ, Else JG, Silvestri G, Goodall J, Sharp PM, Shaw GM, Pusey AE, Hahn BH. 2009. Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz. Nature 460:515-519. http://dx.doi.org/10.1038/nature08200.
58. Horowitz A, Strauss-Albee DM, Leipold M, Kubo J, Nemat-Gorgani N, Dogan OC, Dekker CL, Mackey S, Maecker H, Swan GE, Davis MM, Norman PJ, Guethlein LA, Desai M, Parham P, Blish CA. 2013. Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci. Transl. Med. 5:208ra145. http://dx.doi.org/10.1126 /scitranslmed.3006702.
59. Srour EF, Leemhuis T, Jenski L, Redmond R, Jansen J. 1990. Cytolytic activity of human natural killer cell subpopulations isolated by four-color immunofluorescence flow cytometric cell sorting. Cytometry 11:442-446 http://dx.doi.org/10.1002/cyto.990110316.